Navigating the Updated Anaphylaxis Parameters
<p/> <p>Anaphylaxis, an acute and potentially lethal multi-system clinical syndrome resulting from the sudden, systemic degranulation of mast cells and basophils, occurs in a variety of clinical scenarios and is almost unavoidable inmedical practice. Healthcare professionalsmust be able...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-06-01
|
| Series: | Allergy, Asthma & Clinical Immunology |
| Subjects: | |
| Online Access: | http://www.aacijournal.com/content/3/2/40 |
| _version_ | 1818789388112363520 |
|---|---|
| author | Kemp Stephen F |
| author_facet | Kemp Stephen F |
| author_sort | Kemp Stephen F |
| collection | DOAJ |
| description | <p/> <p>Anaphylaxis, an acute and potentially lethal multi-system clinical syndrome resulting from the sudden, systemic degranulation of mast cells and basophils, occurs in a variety of clinical scenarios and is almost unavoidable inmedical practice. Healthcare professionalsmust be able to recognize its features, treat an episode promptly and appropriately, and be able to provide recommendations to prevent future episodes. Epinephrine, administered immediately, is the drug of choice for acute anaphylaxis. The discussion provides an overview of one set of evidence-based and consensus parameters for the diagnosis and management of anaphylaxis.</p> |
| first_indexed | 2024-12-18T14:38:46Z |
| format | Article |
| id | doaj.art-0571a35bf3d04a1aac698e293c918b7d |
| institution | Directory Open Access Journal |
| issn | 1710-1484 1710-1492 |
| language | English |
| last_indexed | 2024-12-18T14:38:46Z |
| publishDate | 2007-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Allergy, Asthma & Clinical Immunology |
| spelling | doaj.art-0571a35bf3d04a1aac698e293c918b7d2022-12-21T21:04:26ZengBMCAllergy, Asthma & Clinical Immunology1710-14841710-14922007-06-0132404910.1186/1710-1492-3-2-40Navigating the Updated Anaphylaxis ParametersKemp Stephen F<p/> <p>Anaphylaxis, an acute and potentially lethal multi-system clinical syndrome resulting from the sudden, systemic degranulation of mast cells and basophils, occurs in a variety of clinical scenarios and is almost unavoidable inmedical practice. Healthcare professionalsmust be able to recognize its features, treat an episode promptly and appropriately, and be able to provide recommendations to prevent future episodes. Epinephrine, administered immediately, is the drug of choice for acute anaphylaxis. The discussion provides an overview of one set of evidence-based and consensus parameters for the diagnosis and management of anaphylaxis.</p>http://www.aacijournal.com/content/3/2/40anaphylaxisepinephrinemanagementprevention |
| spellingShingle | Kemp Stephen F Navigating the Updated Anaphylaxis Parameters Allergy, Asthma & Clinical Immunology anaphylaxis epinephrine management prevention |
| title | Navigating the Updated Anaphylaxis Parameters |
| title_full | Navigating the Updated Anaphylaxis Parameters |
| title_fullStr | Navigating the Updated Anaphylaxis Parameters |
| title_full_unstemmed | Navigating the Updated Anaphylaxis Parameters |
| title_short | Navigating the Updated Anaphylaxis Parameters |
| title_sort | navigating the updated anaphylaxis parameters |
| topic | anaphylaxis epinephrine management prevention |
| url | http://www.aacijournal.com/content/3/2/40 |
| work_keys_str_mv | AT kempstephenf navigatingtheupdatedanaphylaxisparameters |